ReviewFrontiers in immunology2026
Cradle of rebellion: the relationship between bone marrow microenvironment and autoimmune diseases.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abnormalities in bone marrow microenvironment (BMM) represent a key mechanism closely related to the occurrence and progression of autoimmune diseases (AIDs). They involve dysfunction of critical microenvironment components: reduced supportive function of mesenchymal stromal cells (MSCs) leads to decreased secretion of the anchoring factor CXCL12, disrupting the quiescent state of hematopoietic stem cells (HSCs); dysregulation of sympathetic tone disturbs the circadian rhythm of hematopoietic cell arrangement; and abnormal proliferation of adipocytes fosters a pro-inflammatory environment. Collectively, these changes are related to a functional shift in the microenvironment from homeostasis maintenance to inflammation promotion, directionally biasing HSCs towards differentiation into pro-inflammatory immune lineages and facilitating massive release into the periphery. It establishes a pathogenic vicious cycle: peripheral autoimmune inflammation feeds back to the bone marrow (BM), further remodeling the microenvironment and perpetuating the production of aggressive immune cells, including autoreactive T cells, autoantibody-producing cells, and pro-inflammatory myeloid cells. As a result, patients experience a persistent inflammatory state that resists complete resolution, and disease progression is characterized by systemic involvement, chronicity, and relapsing course. This review focuses on the cellular and molecular components, functional roles, pathological alterations, and mechanisms of the BMM in AIDs. The review aims to provide an essential foundation for further investigation into the pathogenesis of autoimmune diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.